2-[6-(Bis(Carboxymethyl)Amino)-5-[2-[6-(Bis(Carboxymethyl)Amino)-2,3-Difluorophenoxy]Ethoxy]-2-Benzofuran-1-Yl]-1,3-Oxazole-5-Carbox ylic Acid

CAS: 156638-57-2

Ref. 3D-FB103907

Produktinformation

• Name: 2-[6-(Bis(Carboxymethyl)Amino)-5-[2-[6-(Bis(Carboxymethyl)Amino)-2,3-Difluorophenoxy]Ethoxy]-2-Benzofuran-1-Yl]-1,3-Oxazole-5-Carbox ylic Acid
• Synonyme: 2-(2-(5-Carboxyoxazole))-5-(2-(2-bis(carboxymethyl)amino-5,6-difluorophenoxy))ethoxy-6-bis(carboxymethyl)aminobenzofuran, 2-(6-(Bis(carboxymethyl)amino)-5-(2-(6-(bis(carboxymethyl)amino)-2,3-difluorophenoxy)ethoxy)-2-benzofuranyl)-5-oxazolecarboxylic acid, 5-Oxazolecarboxylic acid, 2-(6-(bis(carboxymethyl)amino)-5-(2-(6-(bis(carboxymethyl)amino)-2,3-difluorophenoxy)ethoxy)-2-benzofuranyl)-, 2-{6-[Bis(Carboxymethyl)Amino]-5-(2-{6-[Bis(Carboxymethyl)Amino]-2,3-Difluorophenoxy}Ethoxy)-1-Benzofuran-2-Yl}-1,3-Oxazole-5-Carboxylic Acid

Beschreibung

2-[6-(Bis(Carboxymethyl)Amino)-5-[2-[6-(Bis(Carboxymethyl)Amino)-2,3-Difluorophenoxy]Ethoxy]-2-Benzofuran-1-Yl]-1,3-Oxazole-5-Carbox ylic Acid (CAF01) is a small molecule that has been shown to have neuroprotective effects in animal models of stroke. It prevents neuronal death by inhibiting the release of glutamate and cytosolic calcium levels. CAF01 also inhibits intracellular calcium overload and mitochondrial membrane potential. It protects cells from ischemic brain damage by maintaining the function of neurons and ATP production. CAF01 is a high resistance compound with good bioavailability in vivo.br>
br>
CAF01 is being developed as a treatment for stroke patients who are at high risk of recurrent stroke or death due to cerebral infar

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 663.49 g/mol
• Formel: C₂₈H₂₃F₂N₃O₁₄
• Reinheit: Min. 95%